Exceptional memory aging, or ‘SuperAging’, cannot be explained simply by low inherited Alzheimer's disease risk, according to the findings of a study published in Alzheimer’s Research & Therapy.
#alzsky

SOD1 co-pathologies in the brain: insights from neuropathological evidence and implications.
Acta Neuropathol

This week in Dementia: palamedesreport.org/this-week/dementia
pubmed.ncbi.nlm.nih.gov/42837018

#MedSky #alzsky #dementia

Excited to share our new work now out in Nature Neuroscience!! We use a whole-brain framework to show that aging and Alzhiemer's disease affect the brain's functional organization along completely separate axes.

#MedSky #neuroskyence #neurosky #alzsky #compneuro #datascience #neurology

A Review in the Journal of Translational Medicine shows that synbiotics (combinations of probiotics and prebiotics) have significant potential in early Alzheimer’s, by improving cognitive domains, reducing neuroinflammation, and modulating beneficial microbial metabolites.

#MedSky #alzsky

#EUMIND2026 #alzsky Même en l’absence de troubles cognitifs, la présence d’un syndrome d’apnée du sommeil sévère a des conséquences et d’autant plus en cas d’amyloidopathie sous jacente

Applications are now open for the 2026 MDx Impact Grants. Researchers are invited to explore how high-multiplex PCR could help detect and characterize molecular markers associated with neurodegenerative disease, with a focus on Alzheimer's disease. go.nature.com/4qPmTai #Academicsky #Alzsky

A Review published in Discover Nano explores the potential roles of various exosome-based nanotherapeutic strategies in Alzheimer’s disease treatment, with a particular focus on their mechanisms of action.

#MedSky #alzsky

Exceptional memory aging, or ‘SuperAging’, cannot be explained simply by low inherited Alzheimer's disease risk, according to the findings of a study published in Alzheimer’s Research & Therapy. #alzheimers #alzsky 🧪